On September 4, 1997, Masimo Corporation announced a licensing agreement under which Schiller AG Corporation will integrate Masimo's pulse oximetry signal processing and sensor technologies into its current and future products. Schiller AG is a leading manufacturer of patient monitoring systems and electrocardiographs in Switzerland and is adopting Masimo Signal Extraction Technology (Masimo SET^®) to strengthen its pulse oximetry monitoring capability.

"We are always striving to provide our customers with the best available technology so that they can deliver the highest standard of care possible to their patients," commented Alfred Schiller, President and CEO of Schiller. "The problem of motion artifact, particularly in combination with low peripheral blood perfusion, has long plagued pulse oximetry, particularly in emergency and ambulatory situations, where most of our products are used. Masimo has delivered the first and only real solution to these problems. With Masimo SET, our monitors will now be capable of giving continuous real-time measurement in the most difficult of circumstances."

Joe E. Kiani, President and CEO of Masimo Corporation, stated, "Schiller is an innovative supplier of advanced monitoring equipment tailored to meet the challenging needs of today’s healthcare environment. Our partnership with Schiller is a further indication that Masimo SET is becoming the new standard in pulse oximetry for monitoring patients at risk of respiratory complication. We are delighted to have Schiller as a long-term partner and look forward to working with Schiller to expand the utility of pulse oximetry to new sites and applications."

Schiller AG Corporation is a manufacturer and distributor of patient monitoring systems and electrocardiographs throughout the world. Schiller AG Corporation is located in Baar, Switzerland.